Welcome to our dedicated page for OMEGA HEALTHCARE INVESTORS SEC filings (Ticker: OHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on OMEGA HEALTHCARE INVESTORS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into OMEGA HEALTHCARE INVESTORS's regulatory disclosures and financial reporting.
Robert O. Stephenson, listed as Chief Financial Officer and Officer of Omega Healthcare Investors Inc. (OHI), reported a sale of 800 shares of the issuer's common stock on 08/26/2025. The Form 4 shows the transaction coded as G with a reported price of $0 and indicates 182,276 shares were beneficially owned by the reporting person following the transaction. The filing was signed on behalf of the reporting person by Meghan C. Lyons, Attorney-in-Fact on 08/28/2025. The report is a single-person filing and lists the reporting person’s business address in Hunt Valley, MD.
Insider sale by a director: The Form 4 shows that director Lisa Egbuonu-Davis reported two open-market sales of Omega Healthcare Investors (OHI) common stock on 08/08/2025: 200 shares at $40.16 and 2,300 shares at $40.157318,654 shares beneficially owned.
State Street Corporation reports beneficial ownership of 14,591,873 shares of Omega Healthcare Investors common stock, representing 5% of the class. The filing discloses shared voting power of 11,847,602 shares and shared dispositive power of 14,591,873 shares, with no sole voting or sole dispositive power reported.
The Schedule 13G lists several State Street Global Advisors entities as the relevant subsidiaries and states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.
Omega Healthcare Investors Inc. (OHI) submitted a Form 144 notifying the proposed sale of 2,500 common shares through Fidelity Brokerage, with an aggregate market value of $100,900 and an approximate sale date of 08/08/2025. The filing identifies 295,000 as the number of shares outstanding in the report, which frames the proposed sale size.
The filer shows the shares were received as stock awards: 2,035 shares acquired on 06/03/2022 and 465 shares acquired on 06/10/2024, both recorded as compensation. The notice reports "Nothing to Report" for sales during the past three months and includes the standard signer representation that no undisclosed material adverse information exists.